Showing results (81-90 of 181) with videos related to

Sort By:
Pageof 19
Blood|June 4, 2016
Prognostic impact of cytogenetic aberrations in AL amyloidosis patients after high-dose melphalan: a long-term follow-up studyTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 26, 2023
Application of an artificial intelligence-based tool in [18F]FDG PET/CT for the assessment of bone marrow involvement in multiple myelomaChristos Sachpekidis, Olof Enqvist, Johannes Ulén, et al.
Stem Cells and Development|July 9, 2014
Cell fusion enhances mesendodermal differentiation of human induced pluripotent stem cellsJie Qin, Stephanie Sontag, Qiong Lin, et al.
International Journal of Cancer|November 13, 2004
Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridizationJacek Gronwald, Anna Jauch, Cezary Cybulski, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 25, 2014
Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasoneTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
International Journal of Cancer|January 7, 2021
Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy-resistant preleukemic clonesBorhan R Saeed, Linda Manta, Simon Raffel, et al.
Blood|June 19, 2012
Clinical and prognostic role of annexin A2 in multiple myelomaAnja Seckinger, Tobias Meissner, Jérôme Moreaux, et al.
Plos One|January 4, 2014
The glycome of normal and malignant plasma cellsThomas M Moehler, Anja Seckinger, Dirk Hose, et al.
Plos One|June 24, 2015
KIT Mutation and Loss of 14q May Be Sufficient for the Development of Clinically Symptomatic Very Low-Risk GISTOlaf Karl Klinke, Tuba Mizani, Gouri Baldwin, et al.
Haematologica|March 12, 2010
Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantationKai Neben, Anna Jauch, Uta Bertsch, et al.
Pageof 19